Brief: Adamis Pharmaceuticals Corp Files For Offering On A Reasonable Best Efforts Basis Up To 4.65 Million Units - SEC Filing
13/07/2023 21:49
July 13 (Reuters) - Adamis Pharmaceuticals Corp
ADMP.O :
* ADAMIS PHARMACEUTICALS CORP FILES FOR OFFERING ON A
REASONABLE
BEST EFFORTS BASIS UP TO 4.65 MILLION UNITS - SEC FILING
Further company coverage: ADMP.O
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update